HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner

被引:42
|
作者
Mirambeau, Gilles [1 ,2 ]
Lyonnais, Sebastien [1 ]
Coulaud, Dominique [1 ]
Hameau, Laurence [1 ]
Lafosse, Sophie [1 ]
Jeusset, Josette [1 ]
Borde, Isabelle [3 ]
Reboud-Ravaux, Michele [4 ]
Restle, Tobias [5 ,6 ]
Gorelick, Robert J. [7 ]
Le Cam, Eric [1 ]
机构
[1] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR Interact Mol & Canc 8126,Lab Microscopie Mol, Villejuif, France
[2] Univ Paris 06, Div Biochim, UFR Sci Vie, Paris, France
[3] Univ Paris 06, Lab Biol & Multimedia, Paris, France
[4] Univ Paris 06, CNRS, Inst Jacques Monod, Lab Enzymol Mol & Fonct,FRE 2852, Paris, France
[5] Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany
[6] ZMSB, Lubeck, Germany
[7] NCI, AIDS Vaccine Program, Basic Res Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA
来源
PLOS ONE | 2007年 / 2卷 / 08期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0000669
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6 and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably, escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful replication.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro
    Ji, XD
    Klarmann, GJ
    Preston, BD
    BIOCHEMISTRY, 1996, 35 (01) : 132 - 143
  • [12] HIV-1 reverse transcriptase inhibitors
    El Safadi, Yazan
    Vivet-Boudou, Valerie
    Marquet, Roland
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (04) : 723 - 737
  • [13] Vertical transmission of HIV-1 variants resistant to reverse transcriptase and protease inhibitors
    De Jose, MI
    Ramos, JT
    Alvarez, S
    Jimenez, JL
    Muñoz-Fernández, MA
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (22) : 2738 - 2739
  • [14] Interplay between protease and reverse transcriptase dimerization in a model HIV-1 polyprotein
    Chagas, Brisa Caroline Alves
    Zhou, Xiaohong
    Guerrero, Michel
    Ilina, Tatiana V.
    Ishima, Rieko
    PROTEIN SCIENCE, 2024, 33 (07)
  • [15] HIV-1 reverse transcriptase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 122
  • [16] Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
    Jiang, Y.
    Ng, T. B.
    Wang, C. R.
    Zhang, D.
    Cheng, Z. H.
    Liu, Z. K.
    Qiao, W. T.
    Geng, Y. Q.
    Li, N.
    Liu, F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1331 - 1344
  • [17] Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease
    Dunn, Linda L.
    Boyer, Paul L.
    Clark, Patrick K.
    Hughes, Stephen H.
    VIROLOGY, 2013, 444 (1-2) : 241 - 249
  • [18] HIV-1 subtype B protease and reverse transcriptase amino acid covariation
    Rhee, Soo-Yon
    Liu, Tommy F.
    Holmes, Susan P.
    Shafer, Robert W.
    PLOS COMPUTATIONAL BIOLOGY, 2007, 3 (05) : 836 - 843
  • [19] HIV-1 reverse transcriptase inhibitors
    Yazan El Safadi
    Valérie Vivet-Boudou
    Roland Marquet
    Applied Microbiology and Biotechnology, 2007, 75 : 723 - 737
  • [20] Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase
    Kearney, Mary
    Palmer, Sarah
    Maldarelli, Frank
    Shao, Wei
    Polis, Michael A.
    Mican, Joann
    Rock-Kress, Diane
    Margolick, Joseph B.
    Coffin, John A.
    Mellors, John W.
    AIDS, 2008, 22 (04) : 497 - 501